Aptus Capital Advisors’s Patterson-UTI PTEN Stock Holding History
Bought
Maintained
Sold
Other funds holding PTEN
SG
Aptus Capital Advisors's PTEN Position: Q2 2026 in Review
Aptus Capital Advisors increased its Patterson-UTI (PTEN) stake by 0.17% in Q2 2026, buying an estimated $446 and bringing the position to 22,986 shares worth $211K. The position accounts for ﹤0.01% of the portfolio, ranked #1099.
Aptus Capital Advisors first reported a position in PTEN in Q1 2022 and has held it in 9 quarters since. The position peaked at $1.02M in Q1 2022. 438 funds tracked by Wall St. Rank hold PTEN as of Q2 2026.
- Aptus Capital Advisors held 22,986 shares of Patterson-UTI worth $211K as of Q2 2026.
- Aptus Capital Advisors bought 40 Patterson-UTI shares in Q2 2026, an estimated $446.
- Patterson-UTI made up ﹤0.01% of Aptus Capital Advisors's portfolio in Q2 2026, its #1099 holding.
- Aptus Capital Advisors first reported a position in Patterson-UTI in Q1 2022 and has held it in 9 quarters since.
- Aptus Capital Advisors's Patterson-UTI position peaked at $1.02M in Q1 2022.
- 438 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2026.
Based on Aptus Capital Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.